\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\ \(73\)\
\-\ patient\\ is\\ currently\\ undergoing\\ radiation\\ therapy\\.\ \(0\)\
\-\ ct\\:\\ low\\ attenuation\\ focus\\ in\\ the\\ post\\ left\\ parietal\\ lobe\\,\\ with\\ surrounding\\ vasogenic\\ edema\\.\\ second\\ lesion\\ in\\ the\\ left\\ temporal\\ lobe\\,\\ with\\ irregular\\ central\\ high\\ attenuation\\ consistent\\ with\\ hemorrhage\\.\\ there\\ is\\ not\\ a\\ clear\\ connection\\ between\\ the\\ two\\ discrete\\ lesions\\.\\ the\\ cerebral\\ sulci\\ and\\ left\\ lateral\\ ventricle\\ are\\ effaced\\,\\ and\\ there\\ is\\ mild\\ midline\\ shift\\.\ \(0\)\
\-\ mr\\:\\ left\\ posterior\\ parietal\\ and\\ left\\ temporal\\ lesions\\ with\\ peripheral\\ enhancement\\,\\ and\\ surrounding\\ vasogenic\\ edema\\.\\ the\\ temporal\\ lesion\\ has\\ very\\ low\\ central\\ signal\\ on\\ t2\\ weighted\\ images\\.\\ mass\\ effect\\ as\\ seen\\ on\\ ct\\.\ \(0\)\
\-\ glioblastoma\\ multiforme\ \(8\)\
\-\ ddx\\:\\ the\\ primary\\ differential\\ for\\ most\\ brain\\ lesions\\ is\\ metastatic\\ disease\\ vs\\.\\ primary\\ malignancy\\ vs\\ infection\\ \\(abscess\\)\\.\\ a\\ mnemonic\\ for\\ ring\\ enhancing\\ lesions\\ is\\ magical\\ dr\\:\ \(0\)\
\-\ metastatic\\ disease\\ \\‚\\Ä\\ì\\ may\\ favor\\ due\\ to\\ multiplicity\\ and\\ \ \(0\)\
\-\ \\ \\ hemorrhage\ \(2\)\
\-\ abscess\\/cerebritis\\ \\‚\\Ä\\ì\\ hemorrhage\\ would\\ be\\ atypical\\,and\\ \\ \ \(0\)\
\-\ \\ \\ not\\ febrile\ \(1\)\
\-\ gbm\\ \\‚\\Ä\\ì\\ multicentric\\ gbm\\ also\\ common\\,\\ and\\ can\\ hemorrhage\ \(0\)\
\-\ ischemic\\:\\ hemorrhagic\\ stroke\\ \\‚\\Ä\\ì\\ despite\\ known\\ \ \(0\)\
\-\ \\ \\ hypertension\\,\\ unlikely\\ to\\ have\\ defined\\ enhancing\\ \ \(1\)\
\-\ \\ \\ tissue\ \(3\)\
\-\ contusion\\ \\‚\\Ä\\ì\\ no\\ history\\ of\\ trauma\\,\\ and\\ unlikely\\ with\\ \ \(0\)\
\-\ \\ \\ enhancing\\ soft\\ tissue\\ mass\ \(1\)\
\-\ aids\\:\\ toxo\\ \\‚\\Ä\\ì\\ no\\ history\\ to\\ suggest\ \(0\)\
\-\ lymphoma\\ \\‚\\Ä\\ì\\ would\\ be\\ atypical\\ in\\ an\\ otherwise\\ healthy\\ \ \(0\)\
\-\ \\ \\ individual\ \(1\)\
\-\ demylinating\\ disease\\ \\‚\\Ä\\ì\\ hemorrhage\\ would\\ be\\ \ \(0\)\
\-\ \\ \\ uncharateristic\\,\\ and\\ not\\ comon\ \(1\)\
\-\ radiation\\ necrosis\\ \\‚\\Ä\\ì\\ no\\ history\\ of\\ radiation\\ therapy\ \(0\)\
\-\ 61\\ year\\ old\\ white\\ male\\ with\\ 2\\ weeks\\ of\\ difficulty\\ concentrating\\ and\\ remembering\\,\\ slower\\ movements\\.\\ high\\ blood\\ pressure\\,\\ otherwise\\ healthy\\,\\ though\\ wife\\ has\\ noticed\\ subtle\\ changes\\ in\\ mentation\\ over\\ last\\ 6\\ months\ \(0\)\
\-\ this\\ gentleman\\‚\\Ä\\ôs\\ acute\\ presentation\\ is\\ likely\\ due\\ to\\ acute\\ hemorrhage\\.\ \(0\)\
\-\ gbms\\ are\\ the\\ most\\ malignant\\ of\\ all\\ gliomas\\ \\(who\\ grade\\ iv\\)\\.\\ they\\ are\\ the\\ most\\ common\\ primary\\ brain\\ tumor\\,\\ occuring\\ in\\ all\\ ages\\ with\\ peak\\ at\\ 65\\-75\\ years\\ of\\ age\\.\\ the\\ are\\ more\\ common\\ in\\ men\\ \\(men\\ \\>\\ women\\ 3\\:2\\)\\,\\ and\\ more\\ common\\ in\\ whites\\.\\ they\\ can\\ be\\ associated\\ with\\ certain\\ conditions\\,\\ to\\ included\\ turcot\\ syndrome\\,\\ neurofibromatosis\\ type\\-1\\ and\\ li\\-faumeni\\ syndrome\\.\\ gbms\\ prefer\\ the\\ hemispheric\\ white\\ matter\\,\\ frontal\\ more\\ than\\ temporal\\.\\ \ \(0\)\
\-\ gbms\\ are\\ most\\ commonly\\ a\\ solitary\\ lesion\\,\\ but\\ they\\ can\\ be\\ multifocal\\ in\\ 2\\-5\\%\\ of\\ cases\\.\\ 5\\%\\ of\\ lesions\\ will\\ present\\ with\\ hemorrhage\\;\\ they\\ rarely\\ calcify\\.\\ they\\ can\\ also\\ present\\ as\\ a\\ \\‚\\Ä\\úbutterfly\\ glioma\\,\\‚\\Ä\\ù\\ crossing\\ the\\ midline\\,\\ usually\\ across\\ the\\ corpus\\ callosum\\.\\ they\\ can\\ present\\ as\\ a\\ primary\\ leptomeningeal\\ tumor\\,\\ or\\ metastasize\\ by\\ meningeal\\ or\\ subependymal\\ routes\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hemorrhage\\:\\ 0\\.2511426739354719\ \(0\)\
\-\ gbms\\:\\ 0\\.23755539363636688\ \(0\)\
\-\ they\\:\\ 0\\.229731414981287\ \(0\)\
\-\ temporal\\:\\ 0\\.16465513993372527\ \(0\)\
\-\ lesions\\:\\ 0\\.153876753348225\ \(0\)\
\-\ can\\:\\ 0\\.14060256024620008\ \(0\)\
\-\ and\\:\\ 0\\.1328759984497335\ \(0\)\
\-\ primary\\:\\ 0\\.13179973426009867\ \(0\)\
\-\ the\\:\\ 0\\.12830944735246777\ \(0\)\
\-\ common\\:\\ 0\\.1215587959941802\ \(0\)\
\-\ would\\:\\ 0\\.11379875887354814\ \(0\)\
\-\ gbm\\:\\ 0\\.11331883003724197\ \(0\)\
\-\ most\\:\\ 0\\.1115522065570819\ \(0\)\
\-\ men\\:\\ 0\\.10912642984000738\ \(0\)\
\-\ be\\:\\ 0\\.10868955987014821\ \(0\)\
\-\ in\\:\\ 0\\.10664471170591512\ \(0\)\
\-\ radiation\\:\\ 0\\.10653265504268576\ \(0\)\
\-\ vasogenic\\:\\ 0\\.10541845922728238\ \(0\)\
\-\ are\\:\\ 0\\.10166825061453294\ \(0\)\
\-\ enhancing\\:\\ 0\\.10070628567608718\ \(0\)\
\-\ unlikely\\:\\ 0\\.09494455235029171\ \(0\)\
\-\ with\\:\\ 0\\.09443620830999166\ \(0\)\
\-\ left\\:\\ 0\\.09139766643138768\ \(0\)\
\-\ healthy\\:\\ 0\\.09091342272768434\ \(0\)\
\-\ more\\:\\ 0\\.08827420538258332\ \(0\)\
\-\ is\\:\\ 0\\.08805020790084264\ \(0\)\
\-\ atypical\\:\\ 0\\.08792493010394033\ \(0\)\
\-\ parietal\\:\\ 0\\.08654049218316161\ \(0\)\
\-\ magical\\:\\ 0\\.08569652345128279\ \(0\)\
\-\ uncharateristic\\:\\ 0\\.08569652345128279\ \(0\)\
\-\ comon\\:\\ 0\\.08569652345128279\ \(0\)\
\-\ remembering\\:\\ 0\\.08569652345128279\ \(0\)\
\-\ not\\:\\ 0\\.08461874562453281\ \(0\)\
\-\ present\\:\\ 0\\.0824909632553125\ \(0\)\
\-\ attenuation\\:\\ 0\\.08200223012165586\ \(0\)\
\-\ toxo\\:\\ 0\\.08188760316388714\ \(0\)\
\-\ mentation\\:\\ 0\\.08188760316388714\ \(0\)\
\-\ turcot\\:\\ 0\\.08188760316388714\ \(0\)\
\-\ vs\\:\\ 0\\.08176186982951239\ \(0\)\
\-\ midline\\:\\ 0\\.08060413771823675\ \(0\)\
\-\ routes\\:\\ 0\\.07708893111350501\ \(0\)\
\-\ lesion\\:\\ 0\\.07707172019103457\ \(0\)\
\-\ otherwise\\:\\ 0\\.0763967730386615\ \(0\)\
\-\ effaced\\:\\ 0\\.07537621092472666\ \(0\)\
\-\ demylinating\\:\\ 0\\.07537621092472666\ \(0\)\
\-\ prefer\\:\\ 0\\.07537621092472666\ \(0\)\
\-\ concentrating\\:\\ 0\\.0739281266383884\ \(0\)\
\-\ of\\:\\ 0\\.07340652386058973\ \(0\)\
\-\ multiplicity\\:\\ 0\\.07267373897296181\ \(0\)\
\-\ central\\:\\ 0\\.07156902929913013\ \(0\)\
\-\ mnemonic\\:\\ 0\\.071567290637331\ \(0\)\
\-\ multicentric\\:\\ 0\\.071567290637331\ \(0\)\
\-\ slower\\:\\ 0\\.071567290637331\ \(0\)\
\-\ surrounding\\:\\ 0\\.07147670524806263\ \(0\)\
\-\ white\\:\\ 0\\.07070974542838475\ \(0\)\
\-\ wife\\:\\ 0\\.06968219949694197\ \(0\)\
\-\ whites\\:\\ 0\\.06968219949694197\ \(0\)\
\-\ abscess\\:\\ 0\\.06881886426760672\ \(0\)\
\-\ disease\\:\\ 0\\.06748116182951086\ \(0\)\
\-\ occuring\\:\\ 0\\.0674167343992279\ \(0\)\
\-\ butterfly\\:\\ 0\\.0674167343992279\ \(0\)\
\-\ to\\:\\ 0\\.06698263319807207\ \(0\)\
\-\ brain\\:\\ 0\\.06681139957008649\ \(0\)\
\-\ gentleman\\:\\ 0\\.06559284186806894\ \(0\)\
\-\ hemispheric\\:\\ 0\\.06559284186806894\ \(0\)\
\-\ metastasize\\:\\ 0\\.06559284186806894\ \(0\)\
\-\ syndrome\\:\\ 0\\.06461048116291275\ \(0\)\
\-\ as\\:\\ 0\\.06458282982772195\ \(0\)\
\-\ calcify\\:\\ 0\\.0645479934468904\ \(0\)\
\-\ favor\\:\\ 0\\.06406614663518402\ \(0\)\
\-\ edema\\:\\ 0\\.06392036360407635\ \(0\)\
\-\ all\\:\\ 0\\.063797566391863\ \(0\)\
\-\ dr\\:\\ 0\\.062353426446405666\ \(0\)\
\-\ gliomas\\:\\ 0\\.06196994653656673\ \(0\)\
\-\ lobe\\:\\ 0\\.061934701118341484\ \(0\)\
\-\ due\\:\\ 0\\.06160508026751418\ \(0\)\
\-\ crossing\\:\\ 0\\.06160150898909764\ \(0\)\
\-\ therapy\\:\\ 0\\.06157787112939804\ \(0\)\
\-\ low\\:\\ 0\\.06149647934902783\ \(0\)\
\-\ history\\:\\ 0\\.06141946711704621\ \(0\)\
\-\ high\\:\\ 0\\.06091014248147395\ \(0\)\
\-\ certain\\:\\ 0\\.060575695940780445\ \(0\)\
\-\ individual\\:\\ 0\\.06025722634778837\ \(0\)\
\-\ meningeal\\:\\ 0\\.06025722634778837\ \(0\)\
\-\ metastatic\\:\\ 0\\.058779059529602454\ \(0\)\
\-\ connection\\:\\ 0\\.05828712147521844\ \(0\)\
\-\ aids\\:\\ 0\\.05828712147521844\ \(0\)\
\-\ acute\\:\\ 0\\.057976525408088425\ \(0\)\
\-\ subependymal\\:\\ 0\\.057096421872671756\ \(0\)\
\-\ leptomeningeal\\:\\ 0\\.056659415018620984\ \(0\)\
\-\ tissue\\:\\ 0\\.05622056910834255\ \(0\)\
\-\ tumor\\:\\ 0\\.056057725994975306\ \(0\)\
\-\ multiforme\\:\\ 0\\.05584203420724517\ \(0\)\
\-\ discrete\\:\\ 0\\.05545855429740624\ \(0\)\
\-\ sulci\\:\\ 0\\.055090116749937156\ \(0\)\
\-\ febrile\\:\\ 0\\.055090116749937156\ \(0\)\
\-\ peak\\:\\ 0\\.05491117889607183\ \(0\)\
\-\ ages\\:\\ 0\\.05473558587161437\ \(0\)\
\-\ 61\\:\\ 0\\.05439394992090692\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.05343780804455215\ \(0\)\
\-\ noticed\\:\\ 0\\.05313956225548033\ \(0\)\
\-\ neurofibromatosis\\:\\ 0\\.05313956225548033\ \(0\)\
\-\ movements\\:\\ 0\\.052850494731225335\ \(0\)\
\-\ contusion\\:\\ 0\\.05270922961364119\ \(0\)\
\-\ no\\:\\ 0\\.05227718708583603\ \(0\)\
\-\ across\\:\\ 0\\.05216450002370091\ \(0\)\
\-\ multifocal\\:\\ 0\\.05203311391984953\ \(0\)\
\-\ ddx\\:\\ 0\\.05092666558421872\ \(0\)\
\-\ callosum\\:\\ 0\\.05047385729113065\ \(0\)\
\-\ also\\:\\ 0\\.050411133659422076\ \(0\)\
\-\ stroke\\:\\ 0\\.049833112176203245\ \(0\)\
\-\ solitary\\:\\ 0\\.04904157444382968\ \(0\)\
\-\ has\\:\\ 0\\.04895352885323379\ \(0\)\
\-\ conditions\\:\\ 0\\.048947162058245744\ \(0\)\
\-\ corpus\\:\\ 0\\.048853689114963975\ \(0\)\
\-\ undergoing\\:\\ 0\\.04866948805059994\ \(0\)\
\-\ women\\:\\ 0\\.04822419363245387\ \(0\)\
\-\ rarely\\:\\ 0\\.047799055324887374\ \(0\)\
\-\ ischemic\\:\\ 0\\.04739232715391669\ \(0\)\
\-\ shift\\:\\ 0\\.04707916637897646\ \(0\)\
\-\ despite\\:\\ 0\\.046628170016319845\ \(0\)\
\-\ though\\:\\ 0\\.046555064952489796\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.04648252441215937\ \(0\)\
\-\ included\\:\\ 0\\.04633910249206484\ \(0\)\
\-\ subtle\\:\\ 0\\.04619783737448071\ \(0\)\
\-\ glioma\\:\\ 0\\.045521721680689034\ \(0\)\
\-\ focus\\:\\ 0\\.04539214785682643\ \(0\)\
\-\ ring\\:\\ 0\\.045138241770850095\ \(0\)\
\-\ difficulty\\:\\ 0\\.045075823246899446\ \(0\)\
\-\ last\\:\\ 0\\.043583406866521034\ \(0\)\
\-\ suggest\\:\\ 0\\.04353048304601604\ \(0\)\
\-\ there\\:\\ 0\\.04264382605459385\ \(0\)\
\-\ irregular\\:\\ 0\\.04137116544258593\ \(0\)\
\-\ currently\\:\\ 0\\.04116378498343132\ \(0\)\
\-\ hypertension\\:\\ 0\\.04100111506082793\ \(0\)\
\-\ necrosis\\:\\ 0\\.04096088393598536\ \(0\)\
\-\ mass\\:\\ 0\\.040937246076285745\ \(0\)\
\-\ ct\\:\\ 0\\.04080178834037337\ \(0\)\
\-\ pressure\\:\\ 0\\.04080166057685355\ \(0\)\
\-\ matter\\:\\ 0\\.04080166057685355\ \(0\)\
\-\ second\\:\\ 0\\.04011677777715936\ \(0\)\
\-\ malignancy\\:\\ 0\\.04011677777715936\ \(0\)\
\-\ weighted\\:\\ 0\\.03997113217299888\ \(0\)\
\-\ commonly\\:\\ 0\\.039651458304216076\ \(0\)\
\-\ ventricle\\:\\ 0\\.03944423034306541\ \(0\)\
\-\ clear\\:\\ 0\\.03884863950675101\ \(0\)\
\-\ grade\\:\\ 0\\.03853337658840783\ \(0\)\
\-\ very\\:\\ 0\\.03844082457579615\ \(0\)\
\-\ peripheral\\:\\ 0\\.03831882346761387\ \(0\)\
\-\ iv\\:\\ 0\\.038288569163547836\ \(0\)\
\-\ defined\\:\\ 0\\.03822835130803202\ \(0\)\
\-\ malignant\\:\\ 0\\.03819838651933075\ \(0\)\
\-\ effect\\:\\ 0\\.03759024503670291\ \(0\)\
\-\ or\\:\\ 0\\.03728359753889604\ \(0\)\
\-\ cerebral\\:\\ 0\\.03712523830113951\ \(0\)\
\-\ presentation\\:\\ 0\\.03688807120333751\ \(0\)\
\-\ available\\:\\ 0\\.036356912187619835\ \(0\)\
\-\ cases\\:\\ 0\\.0360425420724553\ \(0\)\
\-\ between\\:\\ 0\\.03481792924429395\ \(0\)\
\-\ differential\\:\\ 0\\.03481792924429395\ \(0\)\
\-\ known\\:\\ 0\\.034693504202852776\ \(0\)\
\-\ mr\\:\\ 0\\.03467292598368686\ \(0\)\
\-\ frontal\\:\\ 0\\.03448972282166744\ \(0\)\
\-\ will\\:\\ 0\\.03448972282166744\ \(0\)\
\-\ usually\\:\\ 0\\.0337347045380257\ \(0\)\
\-\ age\\:\\ 0\\.03364215252541402\ \(0\)\
\-\ years\\:\\ 0\\.03284782437172402\ \(0\)\
\-\ for\\:\\ 0\\.032483330511417614\ \(0\)\
\-\ changes\\:\\ 0\\.03238546270257052\ \(0\)\
\-\ infection\\:\\ 0\\.03236936337850545\ \(0\)\
\-\ on\\:\\ 0\\.032368102265617746\ \(0\)\
\-\ weeks\\:\\ 0\\.03211545729252911\ \(0\)\
\-\ likely\\:\\ 0\\.03202198434924734\ \(0\)\
\-\ lymphoma\\:\\ 0\\.03191409526662849\ \(0\)\
\-\ two\\:\\ 0\\.031822594998158794\ \(0\)\
\-\ months\\:\\ 0\\.031191694434159808\ \(0\)\
\-\ trauma\\:\\ 0\\.031121009726749162\ \(0\)\
\-\ blood\\:\\ 0\\.031121009726749162\ \(0\)\
\-\ enhancement\\:\\ 0\\.030843472456875173\ \(0\)\
\-\ t2\\:\\ 0\\.030829808522403964\ \(0\)\
\-\ mild\\:\\ 0\\.030376678964177017\ \(0\)\
\-\ signal\\:\\ 0\\.030376678964177017\ \(0\)\
\-\ than\\:\\ 0\\.030376678964177017\ \(0\)\
\-\ who\\:\\ 0\\.0303118481113291\ \(0\)\
\-\ over\\:\\ 0\\.02979646525060321\ \(0\)\
\-\ post\\:\\ 0\\.0291581399064253\ \(0\)\
\-\ consistent\\:\\ 0\\.029055845393325216\ \(0\)\
\-\ soft\\:\\ 0\\.028528326980194873\ \(0\)\
\-\ associated\\:\\ 0\\.028244118481182807\ \(0\)\
\-\ posterior\\:\\ 0\\.027710055620087038\ \(0\)\
\-\ may\\:\\ 0\\.026966430382249357\ \(0\)\
\-\ have\\:\\ 0\\.02676940984081257\ \(0\)\
\-\ lateral\\:\\ 0\\.026593816816355104\ \(0\)\
\-\ but\\:\\ 0\\.026498621633946187\ \(0\)\
\-\ seen\\:\\ 0\\.025228103313833107\ \(0\)\
\-\ images\\:\\ 0\\.024787336622512722\ \(0\)\
\-\ male\\:\\ 0\\.0238587834687563\ \(0\)\
\-\ by\\:\\ 0\\.022755947497443304\ \(0\)\
\-\ an\\:\\ 0\\.02049130827807983\ \(0\)\
\-\ at\\:\\ 0\\.020240309861643914\ \(0\)\
\-\ this\\:\\ 0\\.01841329589723053\ \(0\)\
\-\ patient\\:\\ 0\\.01742900732328591\ \(0\)\
\-\ year\\:\\ 0\\.016514312777326783\ \(0\)\
\-\ old\\:\\ 0\\.015859456837467305\ \(0\)\
